Overview

The HHS Office of the Inspector General’s (OIG) trend of Anti-Kickback Statute (AKS) enforcement proceedings against medical products companies has continued in the past several years. Yet, some recent OIG advisory opinions have found that OIG would not impose administrative sanctions for certain financial arrangements under the AKS. During this webinar, we will discuss recent trends in AKS enforcement as well as safe harbors. We will cover how to comply with AKS requirements, including government expectations and requirements, investigative best practices, self-disclosure, and privilege issues.

Speakers

John Bentivoglio, Partner, Skadden, Arps, Slate, Meagher & Flom LLP
Hannah Bornstein, Partner, Nixon Peabody LLP
Lisa Rachlin, Commercial Counsel, Vertex Pharmaceuticals, Inc.
Jennifer Schwartz, Managing Counsel, Office of the General Counsel, Merck & Co., Inc.

Register

Webinar

$99
  • +$100 for non-members

Webinar & Recording

$149
  • +$100 for non-members
Register Now

To ensure that FDLI is able to provide you with a seat, materials, and meals, please register for programs at least 48 hours in advance. While onsite registration is available on a “space-available” basis; late registrants are not guaranteed materials or meals.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.